Joseph Campbell is a scientist specializing in analytical technology within the pharmaceutical industry. Currently, as a Scientist II at Biogen since August 2021, Campbell supports Quality Control Analytical Methods for clinical and commercial-phase small-molecule programs, ensuring proper validation and transfer of analytical methods. Prior experience includes serving as a Chemical Quality Investigator at Pfizer, where Campbell investigated questionable results in Chemical Quality laboratories, and progressing through various roles at GlaxoSmithKline over an eleven-year period to Investigator, focusing on analytical control strategies in drug development. Earlier positions included Control Scientist at DSM Pharmaceuticals and Associate Scientist at AAIPharma Services Corp., both involving pharmaceutical testing to GMP standards. Campbell holds a Bachelor of Science in Chemistry from the University of North Carolina at Greensboro and completed a Ph.D. program in Analytical Chemistry at Texas A&M University without defending the degree.
This person is not in the org chart
This person is not in any teams
This person is not in any offices